Lung Cancer Trial, Not Yet Recruiting NCT06422637 Sponsor: The First Affiliated Hospital of Guangzhou Medical University Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Not Yet Recruiting

NCT06422637
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are older than 40 years and younger than 75 years, of any gender.
  • People who are willing and able to sign a consent form agreeing to take part in the trial.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are pregnant.
  • People who currently have, or have previously had, any cancer other than lung cancer.
  • People who have had a low-dose CT or CT screening scan within the past 1 to 3 years.
  • People who currently have a fever-related illness, or who have had an acute inflammatory illness requiring medical treatment in the 14 days before a blood sample is taken.
  • People who have taken steroid medications (such as corticosteroids) by mouth or through an injection in the 14 days before a blood sample is taken.
  • People who have received an organ transplant, or who have previously received a bone marrow or stem cell transplant from another person (not their own cells).
  • People who are in poor general health or for whom having blood drawn is not considered suitable.
  • People who have any other significant health condition or circumstance that the research team considers may affect their ability to follow the trial's procedures, give informed consent, or safely take part. (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jianxing He, MD, Department of Medical Oncology of Respiratory, Guangxi Medical University Cancer Hospital

Phone: 86-20-83337792

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
The First Affiliated Hospital of Guangzhou Medical University
Registry
ClinicalTrials.gov
Start date
1 June 2024
Est. completion
1 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Positive Predictive Value

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov